{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T10:09:14Z","timestamp":1783764554840,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hearing Research"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.heares.2022.108646","type":"journal-article","created":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T17:51:17Z","timestamp":1667757077000},"page":"108646","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Manipulating the blood labyrinth barrier with mannitol to prevent cisplatin-induced hearing loss"],"prefix":"10.1016","volume":"426","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8064-8127","authenticated-orcid":false,"given":"Ayesha","family":"Noman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhendu","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trung N.","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heares.2022.108646_bib0037","first-page":"31","article-title":"Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma: a southwest oncology group study","volume":"66","author":"Al-Sarraf","year":"1982","journal-title":"Cancer Treat. Rep."},{"key":"10.1016\/j.heares.2022.108646_bib0009","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/s41467-017-01837-1","article-title":"Cisplatin is retained in the cochlea indefinitely following chemotherapy","volume":"8","author":"Breglio","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.heares.2022.108646_bib0027","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/cne.901520402","article-title":"Osmotic opening of tight junctions in cerebral endothelium","volume":"152","author":"Brightman","year":"1973","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.heares.2022.108646_bib0015","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1056\/NEJMoa1801109","article-title":"Sodium thiosulfate for protection from cisplatin-induced hearing loss","volume":"378","author":"Brock","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.heares.2022.108646_bib0034","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3109\/00016487509121305","article-title":"Cochlear damage resulting from kanamycin and furosemide","volume":"80","author":"Brummett","year":"1975","journal-title":"Acta Otolaryngol."},{"key":"10.1016\/j.heares.2022.108646_bib0002","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3390\/toxics3030304","article-title":"Current view in platinum drug mechanisms of peripheral neurotoxicity","volume":"3","author":"Chiorazzi","year":"2015","journal-title":"Toxics"},{"key":"10.1016\/j.heares.2022.108646_bib0004","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/(SICI)1097-0347(199605\/06)18:3<236::AID-HED5>3.0.CO;2-0","article-title":"Neurotoxicity in a phase I trial of continuous infusion cisplatin with hyperfractionated radiotherapy for locally advanced head and neck cancer","volume":"18","author":"Clamon","year":"1996","journal-title":"Head Neck"},{"key":"10.1016\/j.heares.2022.108646_bib0032","first-page":"365","article-title":"Clinical experience with high-dose cisplatin and radiation for treatment of epithelial malignancies","author":"Coughlin","year":"1988","journal-title":"NCI Monogr."},{"key":"10.1016\/j.heares.2022.108646_bib0006","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1634\/theoncologist.2016-0319","article-title":"A systematic review of strategies to prevent cisplatin-induced nephrotoxicity","volume":"22","author":"Crona","year":"2017","journal-title":"Oncologist"},{"key":"10.1016\/j.heares.2022.108646_bib0033","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1177\/1078155218771461","article-title":"A case-control study analyzing mannitol dosing for prevention of cisplatin-induced acute nephrotoxicity","volume":"25","author":"Dhillon","year":"2019","journal-title":"J. Oncol. Pharm. Pract."},{"key":"10.1016\/j.heares.2022.108646_bib0011","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.heares.2004.02.007","article-title":"Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model","volume":"193","author":"Dickey","year":"2004","journal-title":"Hear. Res."},{"key":"10.1016\/j.heares.2022.108646_bib0013","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1124\/jpet.105.087601","article-title":"Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels","volume":"314","author":"Dickey","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.heares.2022.108646_bib0043","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00280-007-0597-2","article-title":"Effect of N-acetylcysteine route of administration on chemoprotection against cisplatin-induced toxicity in rat models","volume":"62","author":"Dickey","year":"2008","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.heares.2022.108646_bib0014","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12987-017-0075-0","article-title":"Dose escalation study of intravenous and intra-arterial N-acetylcysteine for the prevention of oto- and nephrotoxicity of cisplatin with a contrast-induced nephropathy model in patients with renal insufficiency","volume":"14","author":"Dosa","year":"2017","journal-title":"Fluids Barriers CNS"},{"key":"10.1016\/j.heares.2022.108646_bib0044","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s002280100319","article-title":"Pharmacokinetics of cisplatin and relation to nephrotoxicity in paediatric patients","volume":"57","author":"Erdlenbruch","year":"2001","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.heares.2022.108646_bib0042","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.heares.2019.02.006","article-title":"An optimized, clinically relevant mouse model of cisplatin-induced ototoxicity","volume":"375","author":"Fernandez","year":"2019","journal-title":"Hear. Res."},{"key":"10.1016\/j.heares.2022.108646_bib0018","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1470-2045(16)30625-8","article-title":"Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled, open-label, phase 3 trial","volume":"18","author":"Freyer","year":"2017","journal-title":"Lancet. Oncol."},{"key":"10.1016\/j.heares.2022.108646_bib0001","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/1097-0142(197704)39:4<1372::AID-CNCR2820390404>3.0.CO;2-J","article-title":"High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis","volume":"39","author":"Hayes","year":"1977","journal-title":"Cancer"},{"key":"10.1016\/j.heares.2022.108646_bib0023","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s10162-014-0476-6","article-title":"Systemic lipopolysaccharide compromises the blood-labyrinth barrier and increases entry of serum fluorescein into the perilymph","volume":"15","author":"Hirose","year":"2014","journal-title":"J. Assoc. Res. Otolaryngol."},{"key":"10.1016\/j.heares.2022.108646_bib0022","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/0378-5955(92)90030-Q","article-title":"Permeability changes of the blood-labyrinth barrier measured in vivo during experimental treatments","volume":"61","author":"Inamura","year":"1992","journal-title":"Hear. Res."},{"key":"10.1016\/j.heares.2022.108646_bib0025","first-page":"72","article-title":"Blood-labyrinth barrier and fluid dynamics of the inner ear","volume":"7","author":"Juhn","year":"2001","journal-title":"Int. Tinnitus J."},{"key":"10.1016\/j.heares.2022.108646_bib0039","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1007\/s00405-014-3283-0","article-title":"Is there a gender-related susceptibility for cisplatin ototoxicity?","volume":"272","author":"Kirkim","year":"2015","journal-title":"Eur. Arch. Oto-Rhino-Laryngol."},{"key":"10.1016\/j.heares.2022.108646_bib0003","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/ndt\/12.12.2478","article-title":"Insights into potential cellular mechanisms of cisplatin nn","volume":"12","author":"Kuhlmann","year":"1997","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.heares.2022.108646_bib0046","doi-asserted-by":"crossref","first-page":"14077","DOI":"10.1523\/JNEUROSCI.2845-09.2009","article-title":"Adding insult to injury: cochlear nerve degeneration after \"temporary\" noise-induced hearing loss","volume":"29","author":"Kujawa","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.heares.2022.108646_bib0021","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s40463-017-0245-8","article-title":"Mannitol and the blood-labyrinth barrier","volume":"46","author":"Le","year":"2017","journal-title":"J. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.heares.2022.108646_bib0029","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10162-011-0277-0","article-title":"Primary neural degeneration in the Guinea pig cochlea after reversible noise-induced threshold shift","volume":"12","author":"Lin","year":"2011","journal-title":"J. Assoc. Res. Otolaryngol."},{"key":"10.1016\/j.heares.2022.108646_bib0047","article-title":"Local magnetic delivery of recombinant adeno-associated virus AAV2(quad Y-F) mediated brain-derived neurotrophic factor gene therapy restores hearing after noise injury","author":"Mukherjee","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.heares.2022.108646_bib0031","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"key":"10.1016\/j.heares.2022.108646_bib0030","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000276948","article-title":"Alteration in capillary permeability of horseradish peroxidase in the stria vascularis and movement of leaked horseradish peroxidase after administration of furosemide","volume":"59","author":"Naito","year":"1997","journal-title":"ORL J. Otorhinolaryngol. Relat. Spec."},{"key":"10.1016\/j.heares.2022.108646_bib0026","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1172\/JCI109509","article-title":"Osmotic blood-brain barrier disruption. Computerized tomographic monitoring of chemotherapeutic agent delivery","volume":"64","author":"Neuwelt","year":"1979","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.heares.2022.108646_bib0035","first-page":"5278","article-title":"Pharmacology and neurotoxicity of cis-diamminedichloroplatinum, bleomycin, 5-fluorouracil, and cyclophosphamide administration following osmotic blood-brain barrier modification","volume":"43","author":"Neuwelt","year":"1983","journal-title":"Cancer Res."},{"key":"10.1016\/j.heares.2022.108646_bib0036","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/ana.410140310","article-title":"Neurotoxicity of chemotherapeutic agents after blood-brain barrier modification: neuropathological studies","volume":"14","author":"Neuwelt","year":"1983","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.heares.2022.108646_bib0020","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1200\/JCO.1991.9.9.1580","article-title":"Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function","volume":"9","author":"Neuwelt","year":"1991","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.heares.2022.108646_bib0019","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0022-3565(24)37559-7","article-title":"First evidence of otoprotection against carboplatin-induced hearing loss with a two-compartment system in patients with central nervous system malignancy using sodium thiosulfate","volume":"286","author":"Neuwelt","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.heares.2022.108646_bib0024","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao0935","article-title":"Delivery of therapeutics to the inner ear: the challenge of the blood-labyrinth barrier","volume":"11","author":"Nyberg","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.heares.2022.108646_bib0041","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0378-5955(88)90042-1","article-title":"Effects of cisplatin and thiosulfate upon auditory brainstem responses of guinea pigs","volume":"35","author":"Otto","year":"1988","journal-title":"Hear. Res."},{"key":"10.1016\/j.heares.2022.108646_bib0007","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1055\/s-0039-1684041","article-title":"A review of cisplatin-associated ototoxicity","volume":"40","author":"Paken","year":"2019","journal-title":"Semin. Hear."},{"key":"10.1016\/j.heares.2022.108646_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/COC.0b013e31822e006d","article-title":"Transtympanic injections of N-acetylcysteine for the prevention of cisplatin-induced ototoxicity: a feasible method with promising efficacy","volume":"36","author":"Riga","year":"2013","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.heares.2022.108646_bib0028","first-page":"277","article-title":"Pharmacokinetics of drug entry into cochlear fluids","volume":"105","author":"Salt","year":"2005","journal-title":"Volta Rev."},{"key":"10.1016\/j.heares.2022.108646_bib0005","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0030-6665(20)30766-0","article-title":"Ototoxicity of chemotherapeutic agents","volume":"26","author":"Schweitzer","year":"1993","journal-title":"Otolaryngol. Clin. N. Am."},{"key":"10.1016\/j.heares.2022.108646_bib0045","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jchromb.2016.11.027","article-title":"Development and validation of a LC-MS\/MS assay for quantification of cisplatin in rat plasma and urine","volume":"1046","author":"Shaik","year":"2017","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.heares.2022.108646_bib0010","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3389\/fncel.2017.00338","article-title":"Mechanisms of cisplatin-induced ototoxicity and otoprotection","volume":"11","author":"Sheth","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.heares.2022.108646_bib0038","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bjorl.2018.08.002","article-title":"Protective effect of N-acetylcysteine against cisplatin ototoxicity in rats: a study with hearing tests and scanning electron microscopy","volume":"86","author":"Somdas","year":"2020","journal-title":"Braz. J. Otorhinolaryngol."},{"key":"10.1016\/j.heares.2022.108646_bib0008","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.oraloncology.2018.12.010","article-title":"Predictors of cisplatin-induced ototoxicity and survival in chemoradiation treated head and neck cancer patients","volume":"89","author":"Teft","year":"2019","journal-title":"Oral Oncol."},{"key":"10.1016\/j.heares.2022.108646_bib0040","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1038\/s41598-019-40138-z","article-title":"The genetic vulnerability to cisplatin ototoxicity: a systematic review","volume":"9","author":"Tserga","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heares.2022.108646_bib0012","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0028-3908(03)00194-1","article-title":"Local application of sodium thiosulfate prevents cisplatin-induced hearing loss in the guinea pig","volume":"45","author":"Wang","year":"2003","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.heares.2022.108646_bib0017","doi-asserted-by":"crossref","first-page":"E87","DOI":"10.1002\/lary.24360","article-title":"Cisplatin otoprotection using transtympanic L-N-acetylcysteine: a pilot randomized study in head and neck cancer patients","volume":"124","author":"Yoo","year":"2014","journal-title":"Laryngoscope"}],"container-title":["Hearing Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378595522002143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378595522002143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T11:05:12Z","timestamp":1759921512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378595522002143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":47,"alternative-id":["S0378595522002143"],"URL":"https:\/\/doi.org\/10.1016\/j.heares.2022.108646","relation":{},"ISSN":["0378-5955"],"issn-type":[{"value":"0378-5955","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Manipulating the blood labyrinth barrier with mannitol to prevent cisplatin-induced hearing loss","name":"articletitle","label":"Article Title"},{"value":"Hearing Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heares.2022.108646","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108646"}}